Navigation Links
Ayurvedic nightshade deadly for dengue mosquito
Date:4/2/2008

Mosquitoes responsible for spreading disease are increasingly becoming resistant to synthetic insecticides. Now research published in the online open access journal BMC Complementary and Alternative Medicine suggests that the berries of a weed common to India, Solanum villosum (S villosum), have potential for keeping mosquitoes at bay.

S. villosum is a member of the nightshade family known for its medicinal properties and commonly used as an ayurvedic herb.

Nandita Chowdhury, Anupam Ghosh and Goutam Chandra from Burdwan University, West Bengal, India used juice and extracts from the berries of S. villosum, on Stegomyia aegypti, (S. aegypti), which can spread a number of viruses including dengue fever and yellow fever and is commonly known as the yellow fever mosquito.

The authors found that S. villosum was particularly effective at eliminating S. aegypti larvae. Although it was not as potent as a chemical insecticide such as Malathion, the authors suggest that plant extracts from S. villosum have the potential for use in stagnant water where the mosquitoes breed. The next step is to identify the active compounds in the berries and to test whether these are effective in field trials.

We found that these plants produce two types of phytochemicals. says Chandra. The most interesting are the secondary phytochemicals, such as steroids, terpenoids, flavonoids and alkaloids these act as a repellent which protect against the lethal effects of the larval mosquitoes.

A number of plants have been reported for their anti-mosquito activity. Most of the studies report the active compounds to be steroidal saponins, which are thought to kill larvae by interfering with their cuticle membranes. However, only a few botanicals have moved from the laboratory to field use.

Around two-fifths of the Worlds population is at risk from dengue fever, which is characterized by a high fever, pain and rashes. Dengue hemorrhagic fever is a potentially lethal complication, affecting mainly children.


'/>"/>

Contact: Charlotte Webber
charlotte.webber@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

Related biology news :

1. Deadly genetic disease prevented before birth in zebrafish
2. Research unveils new hope for deadly childhood disease
3. Best treatment identified to reduce deadly Staph infections
4. Northwestern to expose most deadly infectious diseases in 3-D
5. Scripps research team blocks bacterial communication system to prevent deadly staph infections
6. Netting mosquitoes to prevent malaria
7. Researchers put the bite on mosquitoes
8. Earlier bites by uninfected mosquitoes boost West Nile deaths in lab mice
9. USDA Cooperative Agreement funds mosquito project at Rutgers
10. Advance in effort to fight malaria by tricking the mosquitos sense of smell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification ... Used combined in one project, multi-biometric solutions provide a ... ...
(Date:3/7/2017)... March 7, 2017 Brandwatch , the leading social ... The Prince,s Trust to uncover insights to support its reporting, ... The UK,s leading youth charity will be using Brandwatch ... and get a better understanding of the topics and issues that ... ...
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics (OTCQB: ... personalized immune therapies for solid tumor cancers, today ... million financing it announced last Friday, March 17, ... several institutional investors securities totaling 28,843,692 shares, comprised ... and 10,000,000 shares of Class C Warrants pre-funded ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
Breaking Biology Technology: